You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
GeneCapture's platform would allow medical providers of all skill levels to quickly treat bacterial infections with the appropriate antibiotics in remote environments
By chopping RNA-seq reads into smaller bits, UW-Tacoma data scientists are able to cut the alignment step to one minute, but the approach has skeptics.
Working with Amazon and Illumina software tools, startup ICBiome has built a platform to help hospitals spot clusters of pathogens early.
The funding will help the San Francisco-based firm apply low-depth NGS as it builds diagnostic tests to aid therapy selection in more diverse populations.
The two new grants add to a $1.5 million Phase II SBIR grant the company received from the National Institute of General Medical Sciences last year.
The Seattle-based firm has won two grants each worth $1.9 million to develop proximity ligation assays with applications in cytogenetics.
The firm's Nanotrap virus particles provide an alternative to RNA extraction kits and could help improve detection for respiratory viruses, including SARS-CoV-2.
The de novo directional genomic hybridization technology is designed to enable the measurement of simple, complex, and heterogenous structural variants.
The Phase 2 grant is for work the company is doing to analyze the proteomic responses of immune cells in patients with Alzheimer's and related conditions.
The funding supports development of a low-cost platform for detection of antimicrobial resistance elements in complex microbial communities.
23andMe has launched a new tool that estimates someone's risk of developing severe COVID-19 if infected, Bloomberg reports.
The Guardian reports that Pasteur Institute researchers are halting their development of a SARS-CoV-2 vaccine following disappointing initial results.
The Wall Street Journal reports that an increased number of younger patients have been hospitalized as the new SARS-CoV-2 strain spread across the UK.
In Cell this week: proteomic patterns among COVID-19 affected tissue samples, transcriptome atlas of developing intestines, and more.